Baker McKenzie advised Haron Holding S.A. on the public takeover delisting offer to the shareholders of DFV Deutsche Familienversicherung AG (“DFV”) as well as on the preceding ownership control procedures. The delisting offer enables a delisting of DFV according to the rules of the German Stock Exchange Act.
“We are pleased that we were able to support our client in making its existing investment in DFV more profitable and at the same time help DFV on its growth path. In particular, we were able to implement a very tight timetable with upstream ownership control procedures in line with our client’s objectives,” commented Dr Christoph Wolf, lead partner on the transaction.
Haron Holding S.A. as the Bidder (the “Bidder”) already holds voting rights in DFV. The Bidder has entered into a delisting agreement with DFV to achieve the delisting in a timely manner.
DFV is a digital direct insurer that is setting new standards in the insurance industry with modern and scalable IT systems developed in-house.
Baker McKenzie’s Corporate/M&A practice regularly advises on national and international transactions. Most recently, Baker McKenzie’s Public M&A practice advised the main shareholders of Wild Bunch AG on a combined voluntary and mandatory takeover offer and a family office on the delisting takeover offer for Geratherm Medical AG. In the area of private M&A, Baker McKenzie recently advised UBE Corporation on its acquisition of the Urethane Systems business from LANXESS, Grundfos on the acquisition of the C&I business from Culligan, Flipp Operations on joining forces with MEDIA Central to create the world’s leading provider of drive-to-store marketing, VINCI Energies on the acquisition of the Fernao Group, GNMI on agreement to acquire the Surface Solutions Business from Merck, KD Pharma Group on the acquisition of the marine lipids business of dsm-firmenich, Saab on a further investment into Helsing, Freaks 4U Gaming on a strategic acquisition by NODWIN Gaming, Trane Technologies on a strategic investment in Trailer Dynamics, EQT Life Sciences on a EUR 128 million Series B2 financing of Tubulis and Knorr-Bremse on the sale of a majority stake in Kiepe Electric.
